Novartis’ Jeffrey Legos becomes chief of oncology at Pfizer

Jeffrey Legos will lead oncology research and development at Pfizer Inc. (NYSE:PFE) as the company’s chief oncology officer. Legos is joining Pfizer from Novartis AG (SIX:NOVN; NYSE:NVS), where he was for a decade, most recently serving as EVP and global head of oncology and hematology development. He succeeds Roger Dansey, who is retiring.  

Tubulis GmbH, which is innovating on the linker, payload and drug-to-antibody ratio of antibody-drug conjugates, hired Matthew Norkunas as president and CFO. Norkunas was CFO of Generation Bio Co. (NASDAQ:GBIO) and Somalogic Inc. Tubulis raised a $140 million series B2 round last year. ...